Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress. Abstract
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Abstract
Overexpression of SOD in retina: need for increase in H2O2-detoxifying enzyme in same cellular compartment. Abstract
Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion. Abstract
Long-term expression of glial cell line-derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa. Abstract
Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells. Abstract
Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit. Abstract